BOT/BAL
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
BOT/BAL
Jun 28, 2024, 15:58 |
Insight
Updates on BOT/BAL from ESMOGI24
ESMO GI 2024 is held in Munich, Germany, and online from June 26-29. Organized by…
Jun 28, 2024, 13:48 |
Insight
Arndt Vogel: Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at ESMOGI24
Arndt Vogel shared on X: "Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at…
Jun 28, 2024, 13:41 |
Insight
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Agenus shared on their X page: "New data from the NEST clinical trial was presented…
Jun 28, 2024, 13:09 |
Insight
Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC
Vittorio Studiale, Medical Oncology Resident at University Hospital of Pisa, shared on X: "Impressive pathological…
Jun 28, 2024, 13:00 |
Insight
Cathy Eng: Agenus with very promising data in early MSI-s/MSI-H colon cancer
Cathy Eng shared on X/Twitter: "Bot/Bal immunotherapy in colon cancer NEST 1/2. Agenus with very…
Apr 22, 2024, 20:02 |
Blog
Pashtoon Kasi: We underestimate how quickly immunotherapy works
Pashtoon Kasi, Director Colon Cancer Research and Director Precision Medicine Research for Liquid Biopsies at…
Apr 17, 2024, 17:16 |
Insight
Rafeh Naqash: Fantastic discussion on biomarker testing and precison oncology
Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine, replied to the post of Rafeh…
Apr 13, 2024, 15:11 |
Insight
Pashtoon Kasi: BOT/BAL we are at our 12+ patients with MSS colorectal cancer within weeks
Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine, shared a post on X/Twitter: ''We have…
Mar 26, 2024, 15:02 |
Insight
Pashtoon Kasi: With BOT/BAL in our NEST trial, we are seeing ctDNA decline and CLEAR within days to 2-4 weeks
Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine shared on LinkedIn: "We…
Feb 14, 2024, 14:59 |
Blog
Yelena Janjigian is leading the investigator-initiated trial of the First Novel Combination of MiNK's Allogeneic Cell Therapy with Agenus' BOT/BAL
Today MiNK Therapeutics released an announcement of the First Refractory Gastric Cancer Patient Dosed in…
1
2
All:
13
Posts:
1 - 10
Monica Bertagnolli: Molecular Portrait of Key Driver of pancreatic cancer
We need to hurry up, because cancer and patients cannot wait!
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
Facebook
RSS Feed
Twitter
Linkedin
Youtube